Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Injection prevents blinding blood vessel growth in mice

18.06.2003


Researchers at Johns Hopkins’ Wilmer Eye Institute and Regeneron Pharmaceuticals have identified an experimental medicine that stops the blinding blood vessel growth associated with diabetic eye diseases and possibly macular degeneration in laboratory mice.



By injecting a fused protein called VEGF-TRAP (R1R2) into the eyes or bloodstreams of mice, scientists halted new blood vessel growth in the rodents’ eyes and stopped existing blood vessels from leaking. Study results were published recently in the Journal of Cellular Physiology.

VEGF-TRAP was designed to antagonize vascular endothelial growth factor (VEGF), a substance naturally produced in the body that promotes blood vessel formation. Released by the retina (light-sensitive tissue in back of the eye) when normal blood vessels are damaged by disease, VEGF turns on its receptor, igniting a chain reaction that culminates in new blood vessel growth. However, the backup blood vessels are faulty; they leak, bleed and encourage scar tissue that detaches the retina, resulting in severe loss of vision. Such growth is the hallmark of diabetic retinopathy, the leading cause of blindness among young people in developed countries. It’s also believed that VEGF contributes to abnormal blood vessel growth from the choroid layer of the eye into the retina, similar to what occurs during the wet or neovascular form of age-related macular degeneration.


VEGF-TRAP contains a portion of two receptors for VEGF, which, hooked together, form a sponge that soaks up VEGF before it causes additional damage. Scientists tested VEGF-TRAP in two groups of laboratory mice. In the first group, which had a rupture of Bruch’s membrane (the layer between the retina and the choroid), they injected VEGF-TRAP directly into the rodents’ eyes. In a second group of mice genetically engineered to express VEGF in the retina, they gave the mice injections of VEGF-TRAP under the skin.

Mice treated with either system-wide or local injections of VEGF-TRAP had significantly less new blood vessel growth. Also, VEGF-TRAP blocked leaking of blood vessels usually caused by VEGF, the major problem in patients with macular edema or swelling. This indicates that unlike some large molecules now being tested in patients, VEGF-TRAP does not have to be injected directly into the eye. Injections can be given under the skin, and VEGF-TRAP can, through circulation, exert a strong therapeutic effect in the eye against abnormal blood vessel formation. No side effects were identified.

Peter A. Campochiaro, M.D., senior study author and professor of ophthalmology and neuroscience, says if clinical studies demonstrate similar properties, he hopes that eventually patients could self-administer injections at home similar to insulin shots taken by diabetics. Unlike other treatments for macular degeneration and diabetic retinopathy, which require treatment of one eye at a time, the shot could take care of both eyes at once.

"Our data suggest that VEGF-TRAP deserves consideration as a potential treatment for two complications of diabetic retinopathy -- new blood vessel growth and macular edema," Campochiaro says. "It had long-lasting effects and did not cause complications."

Circulating levels of VEGF-TRAP or other anti-VEGF medications could have many additional health benefits, Campochiaro says, as abnormal blood vessel growth has been implicated in tumor growth, hardening of the arteries and arthritis. A clinical trial sponsored by Regeneron Pharmaceuticals is being planned to assess the medication’s effects in people with diabetic retinopathy and macular edema, and in patients with wet age-related macular degeneration.

The study was supported by grants from the Public Health Service, the Foundation Fighting Blindness, Research to Prevent Blindness and Dr. and Mrs. William Lake. Coauthors were Yumiko Saishin, Kyoichi Takahashi and Raquel Lima E. Silva of Hopkins, and Donna Hylton, John S. Rudge and Stanley J. Wiegand of Regeneron, Tarrytown, N.Y.


###
Saishin, Yoshitsugu, et al, "VEGF-TRAP Suppresses Choroidal Neovascularization and VEGF-Induced Breakdown of the Blood-Retinal Barrier," Journal of Cellular Physiology, May 2003, Vol. 195, pages 241-248.

Karen Blum | EurekAlert!
Further information:
http://www.wilmer.jhu.edu
http://www.interscience.wiley.com/jpages/0021-9541
http://www.hopkinsmedicine.org

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>